Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2025-12-24 @ 6:33 PM
NCT ID:
NCT00709657
Eligibility Criteria:
Inclusion Criteria:
* 40 subjects ≥ 50 years of age
* Subjects with all angiographic subtypes of neovascular wet AMD, already scheduled for intravitreal anti-VEGF therapy in one eye
* Good central or eccentric fixation
Exclusion Criteria:
* History or previous Anti-VEGF therapy
* History or previous intravitreal injection with any drug
* Intraocular pressure ≥ 25
* Glaucoma
* History or presence of thromboembolic events
* Diabetes mellitus
* Blood donation during the previous 3 weeks
* Ametropy ≥ 6 dpt
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT00709657
Study Brief:
Protocol Section:
NCT00709657